Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer - To Treat or Not To Treat. van Velsen EFS, Verburg FA. J Clin Endocrinol Metab 2023 Mar 25:dgad171. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

van Velsen EFS, Verburg FA. Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer - To Treat or Not To Treat. J Clin Endocrinol Metab 2023 Mar 25:dgad171. doi: 10.1210.
PMID: 36964916